Mission
THE MISSION OF INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH (ISPOR) IS TO PROMOTE HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING FOR HEALTH GLOBALLY.
Public Charity
INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH
INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH is a Public Charity headquartered in LAWRENCEVILLE, NJ. Financial data from the 2024 filing: $19.7M revenue, $19.4M expenses, $30.2M total assets. 3 publicly reported grants to this organization, totaling roughly $96K, appear in IRS filings.
EIN: 223369741
LAWRENCEVILLE, NJ
Management & Technical Assistance
NTEE: H02
Latest filing: 2024
Total Revenue$19.7M
Total Expenses$19.4M
Total Assets$30.2M
Grant Records3
Funding Total$96K
Filing Years2020–2024
Where $100 goes at International Society for Pharmacoeconomics Outcomes Research
How International Society for Pharmacoeconomics Outcomes Research divides every $100 it spends, from its own Form 990 filings, averaged across 8 years.
$83
Programs
the work itself
$17
Management
running the organization
$0
Fundraising
none reported
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Inside the $83 for programs
$83
Ispor is a global, nonprofit scientific and educational society advancing excellence in health economics and outcomes research (heor) to improve healthcare decision-making worldwide.Ispor has over 18,000 invidividual and…
Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
GENERAL CONTRIBUTION
$34,000
GENERAL CONTRIBUTION
$30,000
GENERAL CONTRIBUTION
$32,000
Showing up to 5 of 3 total records — full history available with membership.
Officers & Directors
DIRECTOR
Amy K O'sullivan Phd
DIRECTOR (UNTIL 06/24)
Andrea Manca Msc Phd
DIRECTOR (UNTIL 06/24)
Beth Devine Phd
PAST PRESIDENT (SINCE JUNE 2024)
Brian O'rourke
CHIEF INFO & ENGAGEMENT OFFICER
Chantal Almonord
DIRECTOR
Dalia Dawoud Phd
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $19.7M | $19.4M | $30.2M |
| 2023 | $18.5M | $17.2M | $27.2M |
| 2022 | $14.6M | $15.2M | $23.9M |
| 2021 | $8.1M | $9.6M | $24.5M |
| 2020 | $14.2M | $9.4M | $26.3M |
Between 2020 and 2024, reported annual revenue grew from $14.2M to $19.7M (+39%), with total assets most recently reported at $30.2M.
Interactive year-over-year charts and full filing details available with membership.